psychotic symptoms

Symptoms of Bipolar Disorder/manic Depression?

Published April 26, 2014

Question by seeingbacknow: symptoms of bipolar disorder/manic depression?
hi my hubby was just told he has bipolar can someone please tell me what the signs are so that I can better understand him.

Best answer:

Answer by… Continue reading →

The New Challenges of 'Designer Drugs'

Published November 14, 2013

The new challenges of 'designer drugs'
The list includes substances that induce dependence, cause excitement or depression of the central nervous system, trigger hallucinations or disorders in movement, in judgment, in behaviour, in perception or in mood, where there are… Continue reading →

Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial.

Published August 2, 2013

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Clin Infect Dis. 2013 Aug; 57 Suppl 2: S97-S104
Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein… Continue reading →

Evaluation of Effect of Allopurinol and Febuxostat in Behavioral Model of Depression in Mice.

Published July 9, 2013

Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice.

Indian J Pharmacol. 2013 May; 45(3): 244-7
Karve AV, Jagtiani SS, Chitnis KA

To evaluate the effects of allopurinol and febuxostat on depression using Forced… Continue reading →

[Borderline Personality Disorders: Diagnosis and Treatment].

Published July 3, 2013

[Borderline personality disorders: diagnosis and treatment].

Bull Acad Natl Med. 2012 Oct; 196(7): 1349-58; discussion 1358-60
Allilaire JF

Borderline personality disorders are complex clinical states with highly polymorphic symptoms and signs, leading to delays in their diagnosis and treatment.… Continue reading →

Circulating Cortisol-Associated Signature of Glucocorticoid-Related Gene Expression in Subcutaneous Fat of Obese Subjects.

Published June 22, 2013

Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.

Obesity (Silver Spring). 2013 May; 21(5): 960-7
Pavlatou MG, Vickers KC, Varma S, Malek R, Sampson M, Remaley AT, Gold PW, Skarulis MC, Kino T

Serum… Continue reading →

Acetaldehyde as a Drug of Abuse: Insight Into AM281 Administration on Operant-Conflict Paradigm in Rats.

Published June 20, 2013

Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats.

Front Behav Neurosci. 2013; 7: 64
Plescia F, Brancato A, Marino RA, Cannizzaro C

Increasing evidence focuses on acetaldehyde (ACD) as the mediator of… Continue reading →

A? Induces Astrocytic Glutamate Release, Extrasynaptic NMDA Receptor Activation, and Synaptic Loss.

Published June 19, 2013

A? induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Proc Natl Acad Sci U S A. 2013 Jun 17;
Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto SI, Dziewczapolski G, Nakamura T, Cao… Continue reading →

Thyroxine, Shape, and Weight: Interaction of Graves’ Disease and Bulimia Nervosa.

Published June 13, 2013

Thyroxine, shape, and weight: interaction of Graves’ disease and bulimia nervosa.

Eat Weight Disord. 2013 Mar; 18(1): 99-101
Teufel M, Giel KE, Lehr J, Becker S, Muthig M, Zipfel S, Kuprion J

A case of a 25-year-old woman with… Continue reading →

Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals.

Published May 16, 2013

Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals.

Clin Neuropharmacol. 2013 May/June; 36(3): 98-99
Rolland B, Geoffroy PA, Jardri R, Cottencin O

Cannabis-induced psychotic symptoms (CIPSs) have both similarities and differences with positive symptoms of schizophrenia, and it… Continue reading →